Vivet Therapeutics

It is not often that a big pharma is tapped by a small player for a deal but the markets have reacted well to Monopar Therapeutics’ move to license AstraZeneca’s late-stage Wilson’s disease drug and r

Scion Life Sciences, an affiliate of the health care investment firm Petrichor, launched on 7 February with two friends and former Apple Tree Partners (ATP) colleagues – Scion co-founders and managing

Rising Leaders Home HealthCap is a family of venture capital funds that has invested more than €1.2bn in life sciences since its inception in 1996. Co-managing partner Mårten Steen, one of In Vivo ’

France's Orphalan , which has been flying under the radar commercializing its Wilson's disease drug across Europe, is now set to tackle the US market after bagging regulatory approval for Cuvrior. Th